Source - SMW
SDL has confirmed the availability of "SDL Multilingual Submission Management", which is a web-based platform that enables biopharmaceutical firms to globally automate the submission of multilingual marketing authorisation applications to regulatory authorities across 100+ languages and markets.

"Submitting local language documents for regulatory approval with one regulatory agency is difficult enough - let alone across dozens of countries where documents need to be translated, reformatted, and orchestrated in a timely fashion," said Kaarin Gordon, SVP of global life sciences, SDL.

"Our proven success in this area for the past decade - combined with the exciting new web-based features that SDL MSM offers - make it a powerful platform to overcome one of the biggest burdens for international regulatory affairs departments."




At 1:13pm: (LON:SDL) SDL PLC share price was +5p at 525.5p